If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Silvia Damian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

letrozole Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Anthracyclines Medicine & Life Sciences
Safety Medicine & Life Sciences
Salivary Glands Medicine & Life Sciences
L-Lactate Dehydrogenase Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

  • 184 Citations
  • 1 h-Index
  • 6 Article
Open Access
L-Lactate Dehydrogenase
Monoclonal Antibodies
CD274 Antigen
Area Under Curve
Neoplasms

Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study

Mariani, G., Galli, G., Cavalieri, S., Valagussa, P., Bianchi, G. V., Capri, G., Cresta, S., Ferrari, L., Damian, S., Duca, M., de Braud, F. & Moliterni, A., Mar 1 2019, In : Breast Journal. 25, 2, p. 237-242 6 p.

Research output: Contribution to journalArticle

Anthracyclines
Breast Neoplasms
Drug Therapy
Paclitaxel
Methotrexate

A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer

Schöffski, P., Cresta, S., Mayer, I. A., Wildiers, H., Damian, S., Gendreau, S., Rooney, I., Morrissey, K. M., Spoerke, J. M., Ng, V. W., Singel, S. M. & Winer, E., Sep 5 2018, In : Breast Cancer Research. 20, 1, p. 109

Research output: Contribution to journalArticle

letrozole
Paclitaxel
Breast Neoplasms
Maximum Tolerated Dose
Phosphatidylinositol 3-Kinase

Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study

Cohen, R. B., Delord, J-P., Doi, T., Piha-Paul, S. A., Liu, S. V., Gilbert, J., Algazi, A. P., Damian, S., Hong, R-L., Le Tourneau, C., Day, D., Varga, A., Elez, E., Wallmark, J., Saraf, S., Thanigaimani, P., Cheng, J. & Keam, B., Feb 21 2018, In : American Journal of Clinical Oncology.

Research output: Contribution to journalArticle

Salivary Glands
Carcinoma
Ligands
Therapeutics
Licensure
184 Citations (Scopus)

Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: Combined results from two phase I trials (ALKA-372-001 and STARTRK-1)

Drilon, A., Siena, S., Ou, S. H. I., Patel, M., Ahn, M. J., Lee, J., Bauer, T. M., Farago, A. F., Wheler, J. J., Liu, S. V., Doebele, R., Giannetta, L., Cerea, G., Marrapese, G., Schirru, M., Amatu, A., Bencardino, K., Palmeri, L., Sartore-Bianchi, A., Vanzulli, A. & 15 others, Cresta, S., Damian, S., Duca, M., Ardini, E., Li, G., Christiansen, J., Kowalski, K., Johnson, A. D., Patel, R., Luo, D., Chow-Maneval, E., Hornby, Z., Multani, P. S., Shaw, A. T. & De Braud, F. G., Apr 1 2017, In : Cancer Discovery. 7, 4, p. 400-409 10 p.

Research output: Contribution to journalArticle

Gene Fusion
Safety
Central Nervous System Diseases
Neoplasms
Gene Targeting